NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
ID: 341592Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/341592

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-171.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a funding opportunity titled "NIDDK Central Repository Non-renewable Sample Access." This initiative allows researchers to apply for access to valuable non-renewable biological samples and associated data from significant clinical studies housed at the NIDDK Central Repository, aimed at advancing research in diabetes, obesity, kidney, and digestive diseases. The program does not provide funding; instead, it facilitates access based on the merit of applications and sample availability, with a submission period running from September 27, 2022, to June 27, 2025. Interested applicants must provide a report from the NIDDK Central Repositories documenting sample availability and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-171-Full-Announcement.html
    PAR-22-171.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has released a funding opportunity titled "NIDDK Central Repository Non-renewable Sample Access". This initiative enables researchers to apply for access to valuable non-renewable biological samples from key clinical studies housed at the NIDDK Central Repository. The goal is to facilitate research in areas including diabetes, obesity, kidney, and digestive diseases by providing necessary biospecimens and associated data for validation and development of clinical methodologies. The period for application submissions spans from September 27, 2022, to June 27, 2025, with a maximum project duration of three years. Importantly, the program does not provide funds; rather, access approvals depend on the merit of applications and sample availability. Applicants must include a detailed volume and impact assessment report from the Repository, demonstrating the proposed samples' availability. Eligibility extends to various organizations including higher education institutions, nonprofits, and governmental entities. The NIH will evaluate applications based on scientific merit, significance, investigator qualifications, and project feasibility, ensuring that impactful research is prioritized while maintaining the integrity of the biological samples available in the Repository.
    Similar Opportunities
    High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)" aimed at supporting innovative research that addresses significant knowledge gaps within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative encourages interdisciplinary approaches to foster advancements in understanding, treating, and preventing diseases related to diabetes, digestive, and kidney disorders, with a focus on generating impactful research resources and hypothesis-generating science. Eligible applicants include a wide range of institutions such as higher education entities, nonprofits, for-profits, and various governmental agencies, with project durations extending up to five years initially and a total funding period of up to ten years. Interested parties should note that the application deadline is October 30, 2024, and are encouraged to contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting investigator-initiated, high-risk clinical trials that involve multiple clinical centers. Applicants must propose hypothesis-driven studies that focus on diseases relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with an emphasis on enhancing diverse perspectives in research. This funding opportunity is crucial for advancing therapeutic studies that can significantly improve clinical practices and public health outcomes. Interested applicants should note that the application period opens on January 5, 2024, with a closing date of November 5, 2026, and are encouraged to consult with NIDDK staff prior to submission. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting high-risk observational studies related to diabetes, digestive, kidney, and metabolic diseases. Applicants must complete all planning activities prior to submission, as these cannot be included in the U01 application, and a Plan for Enhancing Diverse Perspectives (PEDP) is mandatory for consideration. This funding opportunity is crucial for advancing clinical research and addressing health disparities, particularly by encouraging collaboration with underrepresented communities. Interested applicants should note that the application deadline is February 5, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity for high-risk multi-center clinical study implementation planning via Cooperative Agreements (U34). This initiative aims to support the early peer review of proposed clinical studies, assess study designs, and develop essential documentation, including operational manuals, focusing on diseases relevant to NIDDK's mission. The program emphasizes health equity and inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested applicants can apply for up to $225,000 per year for a maximum of two years, with the application submission period opening on September 9, 2024, and the closing date set for June 10, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering Research Education Program Grants (R25) to enhance training in biomedical, behavioral, and clinical research. This funding opportunity aims to support educational activities that develop research skills and provide hands-on experiences in areas critical to NIDDK, including diabetes, digestive diseases, and obesity. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and local governments, with a funding limit of $100,000 per year for up to five years. The application deadline is January 30, 2024, and interested parties can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html.
    Nutrition Obesity Research Centers Research Resource Center (RRC) (P2C- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a funding opportunity for the establishment of a Nutrition Obesity Research Centers (NORC) Research Resource Center (RRC). This grant aims to enhance nutrition and obesity research by providing administrative support, managing collaborative programs, and promoting workforce diversity, particularly for early-to-mid-career researchers from diverse backgrounds. The initiative is critical for addressing health disparities related to obesity and will support a range of activities, including the management of pilot and feasibility studies, with funding set at approximately $1 million over a maximum five-year period, including a direct cost cap of $625,000 for the first year. Interested applicants must submit their proposals by October 9, 2024, and include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, with further inquiries directed to grantsinfo@nih.gov.
    Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)." This grant aims to support translational research that justifies later-phase therapeutic discovery and development efforts related to diseases such as obesity, diabetes, digestive disorders, and kidney diseases. The initiative encourages innovative research on novel small molecules and biologics, with a focus on therapeutics that significantly improve or differentiate from existing treatments. NIH anticipates awarding 3-4 grants annually, with budgets ranging from $250,000 to $300,000 per project for up to five years. Interested applicants must submit their proposals by January 7, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries. Additional details can be found at http://grants.nih.gov/grants/guide/pa-files/PAR-22-111.html.
    Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a non-competitive funding opportunity for a cooperative agreement to support the Human Genetic Cell Repository (HGCR), with a focus on maintaining and distributing a diverse collection of human cell lines and DNA samples for biomedical research. The initiative aims to enhance the repository's capacity by acquiring new cell lines from diverse populations, ensuring ethical practices in sample collection, and promoting inclusivity in research efforts. This funding opportunity provides up to $1.75 million annually for a five-year project period, with applications due by June 10, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the funding announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-055.html.
    Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Silvio O. Conte Digestive Diseases Research Core Centers (DDRCC) program, aimed at enhancing research in digestive and liver diseases. This program seeks to foster collaboration among investigators by providing shared resources that enhance productivity and interdisciplinary research, with proposals required to focus on a central theme related to digestive or liver diseases and demonstrate an existing research base with at least $3 million in annual federal funding. The DDRCC program is critical for promoting integrative research approaches and improving health outcomes in digestive health, with a maximum funding amount of $750,000 in direct costs per year for a project period of up to five years. Applications can be submitted starting January 22, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early-stage Biomedical Data Repositories and Knowledgebases," aimed at supporting the development of new or significantly modified data repositories and knowledgebases that enhance biomedical research. This initiative encourages applications from a diverse range of eligible organizations, including higher education institutions and non-profits, with a funding cap of $350,000 per year for a maximum project duration of four years. The importance of this funding lies in its potential to align with FAIR data principles, thereby improving the ecosystem for biomedical research. Interested applicants should note that the application period opens on September 30, 2023, with a Notice of Award expected by early 2024; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.